Boston Children's Hospital performed its first liver transplant in 1984. Since then, our team has spent more than three decades studying and redefining the medical and surgical care of pediatric liver transplant patients, giving thousands of children with end-stage liver disease a second chance at life.
Thanks to our work with game-changing anti-rejection medications, enhanced medical and surgical techniques and improved postoperative care and infection control, long-term survival rates for children who receive a liver transplant now exceed 90 percent.
But we're not satisfied to help just our patients; we want to help all patients.
In recent years, Boston Children's has led the charge in researching the safety and effectiveness of split-liver transplants. We are now heading a movement that calls for changes in how donor livers are allocated, which will increase the number of split-liver transplants done each year and ultimately help ensure a liver for virtually every small child on the waiting list.